Early and prolonged response to pazopanib in a patient with multiple metastases from renal cell carcinoma: a case report

    loading  Checking for direct PDF access through Ovid

Abstract

Aims and background.

In recent years, targeted agents have replaced cytokine therapy as the standard of care for patients with metastatic renal cell carcinoma.

Methods and study design.

We report a patient with multiple metastases from renal cell carcinoma treated with cytoreductive surgery and pazopanib.

Results and conclusions.

The treatment resulted in an early and prolonged response, without toxicity.

Related Topics

    loading  Loading Related Articles